Corvus Pharmaceuticals, Inc. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Corvus Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Corvus Pharmaceuticals, Inc. for March 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2016 | CRVS | Corvus Pharmaceuti ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 356,888 | 0 | 0 | |
Mar 30 2016 | CRVS | Corvus Pharmaceuti ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 2,130,492 | 0 | 0 | |
Mar 30 2016 | CRVS | Corvus Pharmaceuti ... | Novo A/S | 10% Owner | Buy | P | 15.00 | 666,666 | 9,999,990 | 3,154,046 | 2.5 M to 3.2 M (+26.80 %) |
Mar 30 2016 | CRVS | Corvus Pharmaceuti ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 356,888 | 0 | 2,487,380 | 2.1 M to 2.5 M (+16.75 %) |
Mar 30 2016 | CRVS | Corvus Pharmaceuti ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 2,130,492 | 0 | 2,130,492 | 0 to 2.1 M |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 713,776 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,994,674 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 15.00 | 550,000 | 8,250,000 | 5,258,450 | 4.7 M to 5.3 M (+11.68 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 713,776 | 0 | 4,708,450 | 4 M to 4.7 M (+17.87 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 3,994,674 | 0 | 3,994,674 | 0 to 4 M |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 713,776 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 3,994,674 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 15.00 | 550,000 | 8,250,000 | 5,258,450 | 4.7 M to 5.3 M (+11.68 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | C | 0.00 | 713,776 | 0 | 4,708,450 | 4 M to 4.7 M (+17.87 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | C | 0.00 | 3,994,674 | 0 | 3,994,674 | 0 to 4 M |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | C | 0.00 | 97,746 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | C | 0.00 | 583,510 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | C | 0.00 | 71,863 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | C | 0.00 | 428,998 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | C | 0.00 | 95,001 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | C | 0.00 | 567,121 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | C | 0.00 | 92,278 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | C | 0.00 | 550,864 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | P | 15.00 | 54,777 | 821,655 | 736,033 | 681.3 K to 736 K (+8.04 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | C | 0.00 | 97,746 | 0 | 681,256 | 583.5 K to 681.3 K (+16.75 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | C | 0.00 | 583,510 | 0 | 583,510 | 0 to 583.5 K |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | P | 15.00 | 40,272 | 604,080 | 541,133 | 500.9 K to 541.1 K (+8.04 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | C | 0.00 | 71,863 | 0 | 500,861 | 429 K to 500.9 K (+16.75 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | C | 0.00 | 428,998 | 0 | 428,998 | 0 to 429 K |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | P | 15.00 | 53,239 | 798,585 | 715,361 | 662.1 K to 715.4 K (+8.04 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | C | 0.00 | 95,001 | 0 | 662,122 | 567.1 K to 662.1 K (+16.75 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | C | 0.00 | 567,121 | 0 | 567,121 | 0 to 567.1 K |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | P | 15.00 | 51,712 | 775,680 | 694,854 | 643.1 K to 694.9 K (+8.04 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | C | 0.00 | 92,278 | 0 | 643,142 | 550.9 K to 643.1 K (+16.75 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Buy | C | 0.00 | 550,864 | 0 | 550,864 | 0 to 550.9 K |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | MILLER RICHARD A MD | President and CEO | Option Exercise | C | 0.00 | 62,455 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | MILLER RICHARD A MD | President and CEO | Option Exercise | C | 0.00 | 266,310 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | MILLER RICHARD A MD | President and CEO | Buy | C | 0.00 | 62,455 | 0 | 1,046,993 | 984.5 K to 1 M (+6.34 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | MILLER RICHARD A MD | President and CEO | Buy | C | 0.00 | 266,310 | 0 | 984,538 | 718.2 K to 984.5 K (+37.08 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | LEA LEIV | Chief Financial Off ... | Option Exercise | C | 0.00 | 42,608 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | LEA LEIV | Chief Financial Off ... | Buy | C | 0.00 | 42,608 | 0 | 199,253 | 156.6 K to 199.3 K (+27.20 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | C | 0.00 | 97,746 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | C | 0.00 | 583,510 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | C | 0.00 | 71,863 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | C | 0.00 | 428,998 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | C | 0.00 | 95,001 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | C | 0.00 | 567,121 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | C | 0.00 | 92,278 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | C | 0.00 | 550,864 | 0 | 0 | |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | P | 15.00 | 54,777 | 821,655 | 736,033 | 681.3 K to 736 K (+8.04 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | C | 0.00 | 97,746 | 0 | 681,256 | 583.5 K to 681.3 K (+16.75 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | C | 0.00 | 583,510 | 0 | 583,510 | 0 to 583.5 K |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | P | 15.00 | 40,272 | 604,080 | 541,133 | 500.9 K to 541.1 K (+8.04 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | C | 0.00 | 71,863 | 0 | 500,861 | 429 K to 500.9 K (+16.75 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | C | 0.00 | 428,998 | 0 | 428,998 | 0 to 429 K |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | P | 15.00 | 53,239 | 798,585 | 715,361 | 662.1 K to 715.4 K (+8.04 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | C | 0.00 | 95,001 | 0 | 662,122 | 567.1 K to 662.1 K (+16.75 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | C | 0.00 | 567,121 | 0 | 567,121 | 0 to 567.1 K |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | P | 15.00 | 51,712 | 775,680 | 694,854 | 643.1 K to 694.9 K (+8.04 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | C | 0.00 | 92,278 | 0 | 643,142 | 550.9 K to 643.1 K (+16.75 %) |
Mar 29 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Buy | C | 0.00 | 550,864 | 0 | 550,864 | 0 to 550.9 K |
Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | Jones William Benton | VP Pharmaceutical D ... | Option Exercise | A | 15.00 | 60,000 | 900,000 | 60,000 | |
Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | Krognes Steve E. | Director | Option Exercise | A | 15.00 | 30,000 | 450,000 | 30,000 | |
Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | MILLER RICHARD A MD | President and CEO | Option Exercise | A | 15.00 | 500,000 | 7,500,000 | 500,000 | |
Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Option Exercise | A | 15.00 | 30,000 | 450,000 | 30,000 | |
Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | LEA LEIV | Chief Financial Off ... | Option Exercise | A | 15.00 | 60,000 | 900,000 | 60,000 | |
Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | Verner Erik J. | V.P., Chemistry Res ... | Option Exercise | A | 15.00 | 60,000 | 900,000 | 60,000 | |
Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | Gould Terry P | Director | Option Exercise | A | 15.00 | 30,000 | 450,000 | 30,000 | |
Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | A | 15.00 | 30,000 | 450,000 | 30,000 |